Search - tctmd.com

Displaying 101 - 120 of 132

Sort: Relevancy | Date

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for October 2017

Shelley Wood

October 29, 2017

News Daily News

Excluded From Trials, Patients With Severe Kidney Disease Benefit Less From TAVR

Shelley Wood

October 10, 2017

News Daily News

Hemodynamics of First-Gen Sapien Valve Hold Up Well Over the Years: PARTNER Analysis

Caitlin E. Cox

September 29, 2017

Valve Deterioration and Durability Definitions Now Standardized in New Guide

Shelley Wood

September 25, 2017

News Daily News

Frail Patients Benefit From MitraClip, With Gains in Function and Quality of Life

Michael O'Riordan

September 18, 2017

News Conference News ESC 2017

Leaflet Thrombosis After TAVR Tied to Cardiogenic Shock and Death

Yael L. Maxwell

September 01, 2017

News Daily News

Stent Fracture, Reintervention Lessened With Prestenting Before Melody Pulmonary Valve Implantation

Yael L. Maxwell

August 16, 2017

News Daily News

TAVR Deterioration Rare Over 5 Years: Meta-analysis

Caitlin E. Cox

July 12, 2017

News Daily News

Simple Frailty Test in TAVR Can Help Decide Not Just ‘If’ but ‘How’

Shelley Wood

July 07, 2017

News Daily News

TAVR Use Triples in France, With Docs Treating Lower-Risk Patients

Michael O'Riordan

June 26, 2017

News Conference News EuroPCR 2017

TAVR Durability: Some Reassurances From CoreValve Trials Out to 9 Years

Caitlin E. Cox

May 17, 2017

News Conference News ACC 2017

Leaflet Thrombosis Common After Aortic Valve Implant, More So in TAVR Than in Surgery

Michael O'Riordan

March 19, 2017

News Conference News ACC 2017

SURTAVI Lends More Support to Use of TAVR in Intermediate-Risk Patients

Todd Neale

March 17, 2017

News Daily News

Intracardiac Shunts After TAVR: Rare but Potentially Lethal

Todd Neale

November 28, 2016

News Opinion Editor's Corner TCT 2016

My Takeaways From TCT 2016: Surprises, Presuppositions, and the Gift of the Giveaway

Shelley Wood

November 07, 2016

News Conference News TCT 2016

Midterm Durability of TAVR Valves: PARTNER, Other Studies Boost Confidence

Todd Neale

November 01, 2016

News Industry News

Five Year Echocardiogram Follow-Up Data Demonstrates Sustained Durability After Transcatheter Aortic Valve Replacement In High-Risk And Inoperable Patients

November 01, 2016

News Daily News

At 3 Years Post-TAVR, Valve Performance Holds Steady and Most Mortality Is Noncardiac: FRANCE 2 Registry

Caitlin E. Cox

October 04, 2016

News Daily News

Post-TAVR Cognition Improves in Some Patients and Declines in Others, With Few Signposts to Guide the Way

Shelley Wood

September 29, 2016

News Daily News

Elderly Asymptomatic Patients With Severe AS Are Often Treated Too Late

L.A. McKeown

September 16, 2016

Advertisement

TCTMD’s Top 10 Most Popular Stories for October 2017

Excluded From Trials, Patients With Severe Kidney Disease Benefit Less From TAVR

Hemodynamics of First-Gen Sapien Valve Hold Up Well Over the Years: PARTNER Analysis

Valve Deterioration and Durability Definitions Now Standardized in New Guide

Frail Patients Benefit From MitraClip, With Gains in Function and Quality of Life

Leaflet Thrombosis After TAVR Tied to Cardiogenic Shock and Death

Stent Fracture, Reintervention Lessened With Prestenting Before Melody Pulmonary Valve Implantation

TAVR Deterioration Rare Over 5 Years: Meta-analysis

Simple Frailty Test in TAVR Can Help Decide Not Just ‘If’ but ‘How’

TAVR Use Triples in France, With Docs Treating Lower-Risk Patients

TAVR Durability: Some Reassurances From CoreValve Trials Out to 9 Years

Leaflet Thrombosis Common After Aortic Valve Implant, More So in TAVR Than in Surgery

SURTAVI Lends More Support to Use of TAVR in Intermediate-Risk Patients

Intracardiac Shunts After TAVR: Rare but Potentially Lethal

My Takeaways From TCT 2016: Surprises, Presuppositions, and the Gift of the Giveaway

Midterm Durability of TAVR Valves: PARTNER, Other Studies Boost Confidence

Five Year Echocardiogram Follow-Up Data Demonstrates Sustained Durability After Transcatheter Aortic Valve Replacement In High-Risk And Inoperable Patients

At 3 Years Post-TAVR, Valve Performance Holds Steady and Most Mortality Is Noncardiac: FRANCE 2 Registry

Post-TAVR Cognition Improves in Some Patients and Declines in Others, With Few Signposts to Guide the Way

Elderly Asymptomatic Patients With Severe AS Are Often Treated Too Late

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content